Beneficial Effects of Rosuvastatin Treatment in Patients With Metabolic Syndrome

High-Density Lipoprotein Particle Size and Concentration and Coronary Risk

(2013) Karim El Harchaoui   ANNALS OF INTERNAL MEDICINE

Is statin-induced diabetes clinically relevant? A comprehensive review of the literature

(2013) D. S. H. Bell et al.   DIABETES OBESITY & METABOLISM

Anticoagulant effects of statins and their clinical implications

(2013) Kathleen Brummel-Ziedins et al.   THROMBOSIS AND HAEMOSTASIS

“European Panel on Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses

(2011) Dimitri P. Mikhailidis et al.   Current Vascular Pharmacology

“European Panel On Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses: Executive Summary

(2011) Dimitri P. Mikhailidis et al.   Current Vascular Pharmacology

Risk factors associated with metabolic syndrome in type 2 diabetes mellitus patients according to World Health Organization, Third Report National Cholesterol Education Program, and International Diabetes Federation definitions

(2010) Angel Rodríguez   Diabetes Metabolic Syndrome and Obesity-Targets and Therapy

Statin Therapy and Risk of Developing Type 2 Diabetes: A Meta-Analysis

(2009) S. N. Rajpathak et al.   DIABETES CARE

Evaluation of oxidative stress and inflammation in obese adults with metabolic syndrome

(2008) Jiri Skalicky et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE